Experimentally developed cellular resistance to daunomycin. Resistance mechanisms, the daunomycin-pump and cross resistance to adriamycin, vincristine and vinblastine.
D000818:Animals; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003630:Daunorubicin / Q000276:immunology / Q000494:pharmacology / Q000627:therapeutic use*; D004317:Doxorubicin / Q000627:therapeutic use*; D004351:Drug Resistance; D006801:Humans; D007111:Immunity, Cellular; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000276:immunology; D012334:RNA, Neoplasm / Q000096:biosynthesis; D014747:Vinblastine / Q000276:immunology / Q000627:therapeutic use*; D014750:Vincristine / Q000276:immunology / Q000627:therapeutic use*
D004273:DNA, Neoplasm; D012334:RNA, Neoplasm; D014750:Vincristine; D014747:Vinblastine; D004317:Doxorubicin; D003630:Daunorubicin